Literature DB >> 21174007

Association between γ' fibrinogen levels and inflammation.

Kristine S Alexander1, Theresa E Madden, David H Farrell.   

Abstract

The γ' fibrinogen isoform produces clots that are stiffer and more resistant to breakdown than the more common fibrinogen isoform, γA. Increased levels of γ' fibrinogen are associated with several forms of cardiovascular disease. The purpose of this cross-sectional study was to investigate the relationship between γ' fibrinogen, an emerging risk factor for cardiovascular disease, and inflammatory markers in subjects with a chronic inflammatory state. The 284 subjects for this study came from the Periodontitis And Vascular Events (PAVE) study, and γ' fibrinogen and total fibrinogen in plasma were measured by ELISA. Information on patient demographics and health status, as well as levels of C-reactive protein (CRP), an inflammatory marker, have previously been collected for this study. The mean (SE) γ' fibrinogen level in the subjects was 0.622 (0.017) mg/ml. Levels of γ' fibrinogen were correlated with CRP (p = 0.006), with a one unit increase in CRP associated with a 1.9% increase in γ' fibrinogen, after adjustment for potential confounders. Total fibrinogen was not correlated with γ' fibrinogen in these subjects. The number of dental sites with evidence of tissue inflammation was also significantly associated with γ' fibrinogen levels. These results provide an important step in the evolution of γ' fibrinogen not only as a general risk factor for cardiovascular disease, but as a potentially useful biomarker for assessing a patient's inflammatory state and associated cardiovascular disease risk.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21174007      PMCID: PMC4110682          DOI: 10.1160/TH10-09-0626

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  27 in total

Review 1.  Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?

Authors:  L Drouet; F Paolucci; N Pasqualini; M Laprade; L Ripoll; E Mazoyer; C Bal dit Sollier; N Vanhove
Journal:  Blood Coagul Fibrinolysis       Date:  1999-02       Impact factor: 1.276

2.  Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate.

Authors:  J P Collet; C Nagaswami; D H Farrell; G Montalescot; J W Weisel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-12-01       Impact factor: 8.311

3.  Fibrinogen gamma' chain binds thrombin exosite II.

Authors:  R S Lovely; M Moaddel; D H Farrell
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

4.  Resistance of gammaA/gamma' fibrin clots to fibrinolysis.

Authors:  L A Falls; D H Farrell
Journal:  J Biol Chem       Date:  1997-05-30       Impact factor: 5.157

5.  Evidence that both exosites on thrombin participate in its high affinity interaction with fibrin.

Authors:  Caroline H Pospisil; Alan R Stafford; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2003-04-07       Impact factor: 5.157

6.  gamma and gamma' chains of human fibrinogen are produced by alternative mRNA processing.

Authors:  D W Chung; E W Davie
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

7.  Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen.

Authors:  A J Fornace; D E Cummings; C M Comeau; J A Kant; G R Crabtree
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

8.  Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure.

Authors:  Amy V Cooper; Kristina F Standeven; Robert A S Ariëns
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

9.  Identification and characterization of the thrombin binding sites on fibrin.

Authors:  D A Meh; K R Siebenlist; M W Mosesson
Journal:  J Biol Chem       Date:  1996-09-20       Impact factor: 5.157

10.  Association of gammaA/gamma' fibrinogen levels and coronary artery disease.

Authors:  Rehana S Lovely; Lisa A Falls; Hamid A Al-Mondhiry; Charles E Chambers; Gary J Sexton; Hanyu Ni; David H Farrell
Journal:  Thromb Haemost       Date:  2002-07       Impact factor: 5.249

View more
  18 in total

1.  Assessment of genetic determinants of the association of γ' fibrinogen in relation to cardiovascular disease.

Authors:  Rehana S Lovely; Qiong Yang; Joseph M Massaro; Jing Wang; Ralph B D'Agostino; Christopher J O'Donnell; Jackilen Shannon; David H Farrell
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

Review 2.  Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.

Authors:  Harvey A Schenkein; Bruno G Loos
Journal:  J Clin Periodontol       Date:  2013-04       Impact factor: 8.728

3.  High fibrinogen γ' levels in patient plasma increase clot formation at arterial and venous shear.

Authors:  Fraser L Macrae; Frauke Swieringa; Johan W M Heemskerk; Robert A S Ariëns
Journal:  Blood Adv       Date:  2021-09-14

4.  Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6.

Authors:  Chantelle M Rein-Smith; Nathan W Anderson; David H Farrell
Journal:  Thromb Res       Date:  2012-10-01       Impact factor: 3.944

5.  The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.

Authors:  B L Walton; T M Getz; W Bergmeier; F-C Lin; S Uitte de Willige; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

6.  Primed to Understand Fibrinogen in Cardiovascular Disease.

Authors:  Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01       Impact factor: 8.311

7.  Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.

Authors:  Kristine S Alexander; Steven C Kazmierczak; Caryn K Snyder; Jon A Oberdorf; David H Farrell
Journal:  Clin Chem Lab Med       Date:  2013-09       Impact factor: 3.694

8.  γ' fibrinogen levels are associated with blood clot strength in traumatic brain injury patients.

Authors:  David H Farrell; Elizabeth A Rick; Elizabeth N Dewey; Martin A Schreiber; Susan E Rowell
Journal:  Am J Surg       Date:  2019-12-28       Impact factor: 2.565

9.  A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve.

Authors:  Sanela Kjellqvist; Shohreh Maleki; Therese Olsson; Maggy Chwastyniak; Rui Miguel Mamede Branca; Janne Lehtiö; Florence Pinet; Anders Franco-Cereceda; Per Eriksson
Journal:  Mol Cell Proteomics       Date:  2012-11-26       Impact factor: 5.911

10.  Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Duke Appiah; Pamela J Schreiner; Richard F MacLehose; Aaron R Folsom
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-10-22       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.